BioHealth News Archive
6th Annual Maryland Stem Cell Research Symposium – December 3, 2013
The Symposium is the Maryland Stem Cell Research Fund premier event that delivers comprehensive scientific talks, poster presentations, Ethics discussions and networking time, enabling…
Read More
Futuristic “Human-on-Chip” Models Will Help Drug Development – Xconomy
The pharmaceutical industry needs better scientific models for testing drugs before they get to the proving ground of human clinical trials. Current lab dish…
Read More
15 Maryland tech companies among fastest growing in North America – MDBIZNews
Millennial Media, WeddingWire and RainKing Solutions led the list of Maryland companies making the 2013 Deloitte Technology Fast 500, a prestigious technology awards program in United States and Canada.…
Read More
QIAGEN Announces Third Co-Development Program for Companion Diagnostics Paired With Lilly’s Investigational Cancer Compounds – WSJ.com
QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced an agreement with Eli Lilly and Company (NYSE: LLY) to develop and commercialize a molecular…
Read More
Maryland entrepreneurs share crowdfunding success stories – Baltimore Business Journal
For budding startups, accumulating funding is necessary — but difficult. Crowdfunding can be a viable alternative for entrepreneurs. That was one key takeaway for…
Read More
No luck landing VC? Try ‘credit cards, duct tape and shoestrings’ – Baltimore Business Journal
Paul Silber had some unexpected advice from a venture capitalist for the entrepreneurs who crowded a conference room at the BWI Airport Marriott Monday…
Read More
Why Can’t You Take Your Medical Data on Holiday?: Scientific American
We’ve all done it. You throw your clothes in a bag and head to the airport. Sixteen hours later, you’re in a country where…
Read More
What’s driving the surge in new-drug approvals? | McKinsey & Company
Much has been written about the pharmaceutical industry’s R&D-productivity challenge during the past decade: the decline in new-drug approvals has raised discovery and development…
Read More
GlaxoSmithKline’s $15 million new asthma drug approved
GlaxoSmithKline and Theravance's new inhaled lung drug Relvar has been approved in Europe to treat both asthma and chronic obstructive pulmonary disease (COPD), confirming…
Read More
QIAGEN announces third co-development program for companion diagnostics paired with Lilly’s investigational cancer compounds
QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced an agreement with Eli Lilly and Company (NYSE: LLY) to develop and commercialize a molecular…
Read More
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List – Xconomy
We’ve heard a lot this year about the IPO boom for biotech companies. Even after a few high-profile blowups (Ariad, Sarepta), the public biotech…
Read More
MedImmune appoints head of research – PMLiVE
AstraZeneca (AZ) has strengthened its research team by appointing leading academic Dr Yong-Jun Liu as head of research at its MedImmune subsidiary. AZ has…
Read More
Pfizer latest big pharma investor in Mission following £20m funding round | Cambridge technology news | Cabume
A Cambridge company developing new drugs focused around DNA damage and genetically defined cancers has attracted investment from another pharma giant, Pfizer, in its…
Read More
BioEquity Europe – Call for Presenting Companies
Apply Now to be a Presenting Company at Bio€quity Europe 2014Now celebrating its 15th meeting, Bio€quity Europe is the premier industry event for financial…
Read More
Risk Calculator for Cholesterol Appears Flawed – NYTimes.com
Last week, the nation’s leading heart organizations released a sweeping new set of guidelines for lowering cholesterol, along with an online calculator meant to…
Read More